Google
VTVT — VTV THERAPEUTICS INC (Healthcare >> Biotechnology)
VTVT FAQ
What is VTVT's P/E ratio?
VTV THERAPEUTICS INC (VTVT) currently trades at a P/E ratio of 5.25.
What is VTVT's ROE?
VTV THERAPEUTICS INC reports a Return on Equity (ROE) of 2.50%.
What is VTVT's dividend yield?
VTV THERAPEUTICS INC offers a dividend yield of 0.00%.
What is VTVT's Deepscope Quality Score?
Deepscope rates VTVT's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy VTVT?
Deepscope's AI Timing Score for VTVT is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does VTVT belong to?
VTV THERAPEUTICS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 32.14
Price
-2.21
(-6.42%)
Day Change
|
|
|---|
VTVT, the overall quality is not quite good ( Quality = 54) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
Acceleration of ROE growth rate is below our criteria.
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
47% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 96 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 32.14 |
| PBV / Sector |
1.41 / 4.63
GOOD
|
| Earning Per Share | 0.57 |
| PE / Sector |
5.25 / 17.43
GREAT
|
| PEG or PE/Growth / Sector |
-0.23 / 0.53
|
| Average 1M Daily Value |
1.55 M
GREAT
|
| Average 1W Daily Value |
1.22 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
47% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:09:19 |
| Symbol | VTVT |
| Name | VTV THERAPEUTICS INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 3.94 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 126.59 / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 3980 Premier Drive, High Point, NC, United States, 27265
Phone: 336 841 0300
Website: https://vtvtherapeutics.com
Sector: Healthcare >> Biotechnology
Description: vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and liver-selective glucokinase activator that is in Phase III clinical trial to treat type 1 diabetes. The company is also investing a range of molecules across various indications for chronic diseases. It has a license agreement Newsoara Biopharma Co., Ltd. to develop and commercialize phosphodiesterase type 4 inhibitors program. vTv Therapeutics Inc. was incorporated in 2015 and is headquartered in High Point, North Carolina.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
